not vested
Greener pastures still aheadIn our view, SUCB is undervalued at current valuations (7x CY21 P/E) given its robust earnings prospects for at least the next 12 months.
SUCB should post stronger results in upcoming quarters, backed by:
i) further ASP hikes
ii) increases in capacity, and
iii) better economies of scale
Retain Add on SUCB, with an upside of 51.9% and CY21F div yield of 5.6%.
TP: RM 10.80
Source: CIMB
https://rfs.cgs-cimb.com/api/download?f ... B3C0132D32
It's all about "how much you made when you were right" & "how little you lost when you were wrong"